call us now : (858) 35.6-2870
Genetic testing to guide physicians in practicing personalized medicine
We represent the leading Laboratories in the field of biomarker analysis, genetics and specialized testing for unique disease states. Testing consists of products related to clinical depression, PTSD, Autism, Breast Cancer (BRCA), nutrition genetics, cancers and various other state-of-the art laboratory tests. DNA testing that determines the genetic variation associated with a particular patient can help them receive optimum therapeutic response and avoids adverse drug reactions (ADRs).
Ancillary revenue opportunities for medical practices
We represent two organizations involved in the ancillary revenue space. One provides physicians with an end-to-end solution to dispense prescription drugs directly from their offices, ensuring that patients actually receive the drugs thereby improving outcomes, increasing patient satisfaction and substantially increasing practice revenue. Another client offers primary care doctors turnkey solutions to diagnose and treat allergy suffering patients within their practice, maintaining the patient relationship and the continuity of care. Both solutions generate net revenue well in excess of $100,000 for an average medical office.
Safe, early and accurate testing for expectant mothers
Our laboratory client offers accurate and robust testing for common chromosomal abnormalities . The non-invasive prenatal test is performed using a typical maternal blood draw and helps to avoid unnecessary amniocentesis tests and the anxiety and real risks to mother and baby that they entail.
Enabling individuals to eat according to their genes
Our unique genetic makeup determines how our bodies process nutrients. We represent a biotech company founded by some of the global leaders in nutrigenomics research, dedicated to empowering healthcare professionals and their patients with cutting-edge genomic information to improve health through personal nutrition
The first blood test diagnosing Major Depressive Disorder
A longstanding client is a neuro-diagnostic company offering a proprietary first-in-class blood test for Major Depressive Disorder through its CLIA certified laboratory. Based upon its proprietary human biomarker library our client has developed multi-variant biological marker assays and diagnostic algorithms to diagnose, select and monitor treatment for MDD and other neuropsychiatric disorders.
A genetic test for psychiatric drug response
Another long-term client utilizes modern genetic technology to discover the underlying genetic basis for psychiatric illnesses and drug response. They develop their genetic discoveries into molecular diagnostic tests – personalized medicine — used to improve the care of people with serious mental illness. The test accurately predicts whether antidepressants, antipsychotics and other drugs are likely to be safe and effective for particular patients — supporting physicians in getting the right drug in the right dosage to the right patient.